Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
PF-07826390 by Pfizer for Solid Tumor: Likelihood of Approval
PF-07826390 is under clinical development by Pfizer and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...
Data Insights
PF-07826390 by Pfizer for Colorectal Cancer: Likelihood of Approval
PF-07826390 is under clinical development by Pfizer and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase I...